Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03980964 · ClinicalTrials.gov registry record · NA

Evaluation of NMES for Reducing Pain and Improving Functional Outcomes in Knee OA Patients

A NA study, sponsored by CyMedica Orthopedics.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03980964 is a NA study that has completed, run by CyMedica Orthopedics. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03980964, a NA study, has completed, sponsored by CyMedica Orthopedics.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The present prospective trial is designed to evaluate the efficacy of CyMedica Orthopedics e-vive™ system, a multifunctional electrotherapy device providing neuromuscular electrical stimulation (NMES) for reducing pain and accelerating functional recovery in patients with knee osteoarthritis. This post-market trial will involve patients who have been diagnosed with knee osteoarthritis, Kelgren-Lawrence Grades II, III, and IV. It is hypothesized that the use of the CyMedica e-vive NMES can reduce pain, improve knee function, and improve quality of life.

Interventions

  • DEVICE Active NMES

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-06-07
Est. Completion 2021-04-16
Phase NA

Sponsor

CyMedica Orthopedics

3 total trials

What the Registry Record Tells You About NCT03980964

The ClinicalTrials.gov registry entry for NCT03980964 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CyMedica Orthopedics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Active NMES is the first listed.

NCT03980964 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03980964 about?

NCT03980964 is a clinical study titled "Evaluation of NMES for Reducing Pain and Improving Functional Outcomes in Knee OA Patients". The present prospective trial is designed to evaluate the efficacy of CyMedica Orthopedics e-vive™ system, a multifunctional electrotherapy device providing neuromuscular electrical stimulation (NMES) for reducing pain and accelerating functional recovery in patients with knee osteoarthritis. This p...

What is the current status of trial NCT03980964?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-06-07. Estimated completion is 2021-04-16.

What interventions are being tested in trial NCT03980964?

The interventions under investigation include: Active NMES (DEVICE).

Who is sponsoring clinical trial NCT03980964?

This trial is sponsored by CyMedica Orthopedics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.